Do Patients with Acute Myocardial Infarction Benefit from Treatment with Clopidogrel?

Andrew Worster, Samuel M Keim, Rajiv Vadera, Peter Rosen

Research output: Contribution to journalArticle

Abstract

Clopidogrel (Plavix), a platelet aggregation inhibitor, has been shown to be effective in certain patients undergoing percutaneous coronary interventions, but its use in patients with acute myocardial infarction who receive a fibrinolytic strategy instead has been controversial. The aim of the Evidence-Based Medicine (EBM) Section is to bring the readership clinically relevant and practical evidence-based medicine principles and topic reviews. This EBM - Therapy review focuses on a relatively new therapy option for Emergency Department patients with acute myocardial infarction.

Original languageEnglish (US)
Pages (from-to)479-483
Number of pages5
JournalJournal of Emergency Medicine
Volume34
Issue number4
DOIs
StatePublished - May 2008

Fingerprint

clopidogrel
Evidence-Based Medicine
Myocardial Infarction
Platelet Aggregation Inhibitors
Percutaneous Coronary Intervention
Hospital Emergency Service
Therapeutics

Keywords

  • clopidogrel
  • drug therapy
  • EBM
  • myocardial infarction
  • platelet aggregation inhibitors

ASJC Scopus subject areas

  • Emergency Medicine

Cite this

Do Patients with Acute Myocardial Infarction Benefit from Treatment with Clopidogrel? / Worster, Andrew; Keim, Samuel M; Vadera, Rajiv; Rosen, Peter.

In: Journal of Emergency Medicine, Vol. 34, No. 4, 05.2008, p. 479-483.

Research output: Contribution to journalArticle

Worster, Andrew ; Keim, Samuel M ; Vadera, Rajiv ; Rosen, Peter. / Do Patients with Acute Myocardial Infarction Benefit from Treatment with Clopidogrel?. In: Journal of Emergency Medicine. 2008 ; Vol. 34, No. 4. pp. 479-483.
@article{b15fa458b3214f828466c39054d4b5f8,
title = "Do Patients with Acute Myocardial Infarction Benefit from Treatment with Clopidogrel?",
abstract = "Clopidogrel (Plavix), a platelet aggregation inhibitor, has been shown to be effective in certain patients undergoing percutaneous coronary interventions, but its use in patients with acute myocardial infarction who receive a fibrinolytic strategy instead has been controversial. The aim of the Evidence-Based Medicine (EBM) Section is to bring the readership clinically relevant and practical evidence-based medicine principles and topic reviews. This EBM - Therapy review focuses on a relatively new therapy option for Emergency Department patients with acute myocardial infarction.",
keywords = "clopidogrel, drug therapy, EBM, myocardial infarction, platelet aggregation inhibitors",
author = "Andrew Worster and Keim, {Samuel M} and Rajiv Vadera and Peter Rosen",
year = "2008",
month = "5",
doi = "10.1016/j.jemermed.2007.10.019",
language = "English (US)",
volume = "34",
pages = "479--483",
journal = "Journal of Emergency Medicine",
issn = "0736-4679",
publisher = "Elsevier USA",
number = "4",

}

TY - JOUR

T1 - Do Patients with Acute Myocardial Infarction Benefit from Treatment with Clopidogrel?

AU - Worster, Andrew

AU - Keim, Samuel M

AU - Vadera, Rajiv

AU - Rosen, Peter

PY - 2008/5

Y1 - 2008/5

N2 - Clopidogrel (Plavix), a platelet aggregation inhibitor, has been shown to be effective in certain patients undergoing percutaneous coronary interventions, but its use in patients with acute myocardial infarction who receive a fibrinolytic strategy instead has been controversial. The aim of the Evidence-Based Medicine (EBM) Section is to bring the readership clinically relevant and practical evidence-based medicine principles and topic reviews. This EBM - Therapy review focuses on a relatively new therapy option for Emergency Department patients with acute myocardial infarction.

AB - Clopidogrel (Plavix), a platelet aggregation inhibitor, has been shown to be effective in certain patients undergoing percutaneous coronary interventions, but its use in patients with acute myocardial infarction who receive a fibrinolytic strategy instead has been controversial. The aim of the Evidence-Based Medicine (EBM) Section is to bring the readership clinically relevant and practical evidence-based medicine principles and topic reviews. This EBM - Therapy review focuses on a relatively new therapy option for Emergency Department patients with acute myocardial infarction.

KW - clopidogrel

KW - drug therapy

KW - EBM

KW - myocardial infarction

KW - platelet aggregation inhibitors

UR - http://www.scopus.com/inward/record.url?scp=42749085403&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=42749085403&partnerID=8YFLogxK

U2 - 10.1016/j.jemermed.2007.10.019

DO - 10.1016/j.jemermed.2007.10.019

M3 - Article

VL - 34

SP - 479

EP - 483

JO - Journal of Emergency Medicine

JF - Journal of Emergency Medicine

SN - 0736-4679

IS - 4

ER -